systemic%20lupus%20erythematosus
SYSTEMIC LUPUS ERYTHEMATOSUS
Systemic lupus erythematosus is a chronic, multisystem, inflammatory, autoimmune disorder characterized by formation of autoantibodies directed against self-antigens and immune-complex formation.
It can be diagnosed with a single organ involvement such as lupus nephritis.
It is predominantly diagnosed in females of childbearing age.
Clinical presentation varies in different patients and the disease activity varies over time in a single patient. Majority of patients have arthralgia of the hand.

Systemic Lupus Erythematosus Drug Information

Drug Information

Indication: Eczema including atopic, infantile, discoid & stasis eczema; prurigo; psoriasis; neurodermatoses including...

Indication: Short-term treatment of corticosteroid-responsive resistant dermatoses eg, psoriasis, recalcitrant eczema, lic...

Indication: Symptomatic treatment of allergic dermatoses & other forms of contact dermatitis, insect bites; atopic, ec...

Indication: Reducing disease activity in adult patients w/ active autoantibody +ve SLE receiving standard therapy.

Indication: Relief of inflammatory manifestations of corticosteroid-responsive dermatoses.

Indication: Relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses (eg, psoriasis, e...

Indication: Acute & chronic rheumatic fever, RA, bronchial asthma, myositis, dermatitis.

Indication: Prophylaxis of acute organ rejection in patients receiving allogeneic renal, cardiac & hepatic transplants...

Indication: Psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematosus & other condition which do not...

Indication: Moderate to severe forms of scalp psoriasis in ≥18 yr.

1  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
05 Jun 2018
Men with systemic lupus erythematosus (SLE) are more likely to develop coronary artery calcifications (CAC) than age- and sex-matched controls, a recent study has shown. Such risk among patients with SLE is associated with older age, increasing chronic damage and cumulative dose of corticosteroids.